Milit Patel is a founding engineer at UViiVe, Inc., where he builds generative AI and structure-based design frameworks for next-generation protein therapeutics. He is also an researcher at The University of Texas at Austin, pursuing a B.S. in Biochemistry with minors in Healthcare Reform & Innovation Business and Statistics & Data Science, while contributing to computational oncology, health services research, and AI-driven drug discovery projects across Harvard T.H. Chan School of Public Health, MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, and Mass General Hospital/Harvard Medical School.
